Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers
Clinical trial NCT02471690 · COMPLETED
Trial details
- NCT number
- NCT02471690
- Sponsor
- The Medicines Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-04-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.